Purine nucleoside phosphorylase. 3. Reversal of purine base specificity by site-directed mutagenesis. 1997

J D Stoeckler, and A F Poirot, and R M Smith, and R E Parks, and S E Ealick, and K Takabayashi, and M D Erion
Section of Molecular & Biochemical Pharmacology, Division of Biology & Medicine, Brown University, Providence, Rhode Island 02912, USA.

Human purine nucleoside phosphorylase (PNP) is highly specific for 6-oxopurine nucleosides with a catalytic efficiency (kcat/KM) for inosine 350000-fold greater than for adenosine. Crystallographic studies identified Asn243 and Glu201 as the residues largely responsible for the substrate specificity. Results from mutagenesis studies demonstrated that the side chains for both residues were also essential for efficient catalysis [Erion, M. D., et al. (1997a) Biochemistry 36, 11725-11734]. Additional mechanistic studies predicted that Asn243 participated in catalysis by stabilizing the transition state structure through hydrogen bond donation to N7 of the purine base [Erion, M. D., et al. (1997b) Biochemistry 36, 11735-11748]. In an effort to alter the substrate specificity of human PNP, mutants of Asn243 and Glu201 were designed to reverse hydrogen bond donor and acceptor interactions with the purine base. Replacement of Asn243 with Asp, but not with other amino acids, led to a 5000-fold increase in kcat for adenosine and a 4300-fold increase in overall catalytic efficiency. Furthermore, the Asn243Asp mutant showed a 2.4-fold preference for adenosine relative to inosine and a 800000-fold change in substrate specificity (kcat/KM) relative to wild-type PNP. The double mutant, Asn243Asp::Glu201Gln, exhibited a 190-fold increase in catalytic efficiency with adenosine relative to wild-type PNP, a 480-fold preference for adenosine relative to inosine, and a 1.7 x 10(8)-fold change in preference for adenosine over inosine relative to wild-type PNP. The Asn243Asp mutant was also shown to synthesize 2,6-diaminopurine riboside with a catalytic efficiency (1.4 x 10(6) M-1 s-1) on the same order of magnitude as wild-type PNP with its natural substrates hypoxanthine and guanine. The Asn243Asp mutants represent examples in which protein engineering significantly altered substrate specificity while maintaining high catalytic efficiency.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008956 Models, Chemical Theoretical representations that simulate the behavior or activity of chemical processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment. Chemical Models,Chemical Model,Model, Chemical
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D011683 Purine-Nucleoside Phosphorylase An enzyme that catalyzes the reaction between a purine nucleoside and orthophosphate to form a free purine plus ribose-5-phosphate. EC 2.4.2.1. Inosine Phosphorylase,Nicotinamide Riboside Phosphorylase,Purine Nucleoside Phosphorylases,Nucleoside Phosphorylases, Purine,Phosphorylase, Inosine,Phosphorylase, Nicotinamide Riboside,Phosphorylase, Purine-Nucleoside,Phosphorylases, Purine Nucleoside,Purine Nucleoside Phosphorylase,Riboside Phosphorylase, Nicotinamide
D011688 Purinones Oxopurines
D002384 Catalysis The facilitation of a chemical reaction by material (catalyst) that is not consumed by the reaction. Catalyses
D003198 Computer Simulation Computer-based representation of physical systems and phenomena such as chemical processes. Computational Modeling,Computational Modelling,Computer Models,In silico Modeling,In silico Models,In silico Simulation,Models, Computer,Computerized Models,Computer Model,Computer Simulations,Computerized Model,In silico Model,Model, Computer,Model, Computerized,Model, In silico,Modeling, Computational,Modeling, In silico,Modelling, Computational,Simulation, Computer,Simulation, In silico,Simulations, Computer
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations

Related Publications

J D Stoeckler, and A F Poirot, and R M Smith, and R E Parks, and S E Ealick, and K Takabayashi, and M D Erion
June 2012, Enzyme and microbial technology,
J D Stoeckler, and A F Poirot, and R M Smith, and R E Parks, and S E Ealick, and K Takabayashi, and M D Erion
November 1967, Molecular pharmacology,
J D Stoeckler, and A F Poirot, and R M Smith, and R E Parks, and S E Ealick, and K Takabayashi, and M D Erion
August 1992, Nucleic acids research,
J D Stoeckler, and A F Poirot, and R M Smith, and R E Parks, and S E Ealick, and K Takabayashi, and M D Erion
January 2013, Biomeditsinskaia khimiia,
J D Stoeckler, and A F Poirot, and R M Smith, and R E Parks, and S E Ealick, and K Takabayashi, and M D Erion
June 1979, Nihon rinsho. Japanese journal of clinical medicine,
J D Stoeckler, and A F Poirot, and R M Smith, and R E Parks, and S E Ealick, and K Takabayashi, and M D Erion
September 2013, Carbohydrate research,
J D Stoeckler, and A F Poirot, and R M Smith, and R E Parks, and S E Ealick, and K Takabayashi, and M D Erion
January 1991, Methods in enzymology,
J D Stoeckler, and A F Poirot, and R M Smith, and R E Parks, and S E Ealick, and K Takabayashi, and M D Erion
August 2010, Protein engineering, design & selection : PEDS,
J D Stoeckler, and A F Poirot, and R M Smith, and R E Parks, and S E Ealick, and K Takabayashi, and M D Erion
February 1987, The Journal of biological chemistry,
J D Stoeckler, and A F Poirot, and R M Smith, and R E Parks, and S E Ealick, and K Takabayashi, and M D Erion
November 2004, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!